Aspirin for cancer prevention in individuals with Lynch syndrome: first results from the CaPP3 multicentre, randomised, double-blind, non-inferiority trial
- DOI
- 10.1016/s2468-1253(26)00114-7
- Published
- 2026-09
- Container
- The Lancet Gastroenterology & Hepatology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/s2468-1253-26-00114-7,
title = {Aspirin for cancer prevention in individuals with Lynch syndrome: first results from the CaPP3 multicentre, randomised, double-blind, non-inferiority trial},
author = {John Burn and Gillian M Borthwick and Faye Elliott and Finlay Macrae and Kai Ren Ong and Alison C Kraus and Nadir Arber and Jukka-Pekka Mecklin and Angel Alonso and Emma R Woodward and D Gareth Evans and Alex Murray and Katie Snape and Ruth E Cleaver and Adam Shaw and Huw J W Thomas and Ajith V Kumar and Dorothy Halliday and Lucy E Side and Rachel E Harrison and Rosemarie Davidson and Ruth Armstrong and Jackie Cook and Rachel Hart and Patrick J Morrison and Julian G Barwell and Alan Donaldson and Zoe Kemp and Jennie Murray and Zosia Miedzybrodzka and Caroline Pottinger and Jonathan Berg and Richard Gallon and D Timothy Bishop and Naim Abu-Freha and Alex Boussioutas and Diana M Eccles and Lynn Greenhalgh and Ana Guerra Lacunza and Elizabeth E Half and Helen Hanson and Rachel Hart and Christine M Hayes and Donna Job and Zafirah Khan and Anjana Kulkarni and Zohar Levi and Lynne Longstaff and Helen Mar Fan and John C Mathers and Victoria Murday and Mary EM Porteous and Kirsi Pylvänäinen and Lynn Reed and Dimitra Repana and Toni T Seppala and Shiran Shapira and Allan Spigelman and Helene Thygesen and James Toh and Kathy Wu},
year = {2026},
journal = {The Lancet Gastroenterology \& Hepatology},
doi = {10.1016/s2468-1253(26)00114-7},
url = {https://doi.org/10.1016/s2468-1253(26)00114-7}
}RIS
TY - JOUR TI - Aspirin for cancer prevention in individuals with Lynch syndrome: first results from the CaPP3 multicentre, randomised, double-blind, non-inferiority trial AU - John Burn AU - Gillian M Borthwick AU - Faye Elliott AU - Finlay Macrae AU - Kai Ren Ong AU - Alison C Kraus AU - Nadir Arber AU - Jukka-Pekka Mecklin AU - Angel Alonso AU - Emma R Woodward AU - D Gareth Evans AU - Alex Murray AU - Katie Snape AU - Ruth E Cleaver AU - Adam Shaw AU - Huw J W Thomas AU - Ajith V Kumar AU - Dorothy Halliday AU - Lucy E Side AU - Rachel E Harrison AU - Rosemarie Davidson AU - Ruth Armstrong AU - Jackie Cook AU - Rachel Hart AU - Patrick J Morrison AU - Julian G Barwell AU - Alan Donaldson AU - Zoe Kemp AU - Jennie Murray AU - Zosia Miedzybrodzka AU - Caroline Pottinger AU - Jonathan Berg AU - Richard Gallon AU - D Timothy Bishop AU - Naim Abu-Freha AU - Alex Boussioutas AU - Diana M Eccles AU - Lynn Greenhalgh AU - Ana Guerra Lacunza AU - Elizabeth E Half AU - Helen Hanson AU - Rachel Hart AU - Christine M Hayes AU - Donna Job AU - Zafirah Khan AU - Anjana Kulkarni AU - Zohar Levi AU - Lynne Longstaff AU - Helen Mar Fan AU - John C Mathers AU - Victoria Murday AU - Mary EM Porteous AU - Kirsi Pylvänäinen AU - Lynn Reed AU - Dimitra Repana AU - Toni T Seppala AU - Shiran Shapira AU - Allan Spigelman AU - Helene Thygesen AU - James Toh AU - Kathy Wu PY - 2026 JO - The Lancet Gastroenterology & Hepatology DO - 10.1016/s2468-1253(26)00114-7 UR - https://doi.org/10.1016/s2468-1253(26)00114-7 ER -
APA
Burn, J., Borthwick, G. M., Elliott, F., Macrae, F., Ong, K. R., Kraus, A. C., Arber, N., Mecklin, J., Alonso, A., Woodward, E. R., Evans, D. G., Murray, A., Snape, K., Cleaver, R. E., Shaw, A., Thomas, H. J. W., Kumar, A. V., Halliday, D., Side, L. E., Harrison, R. E., Davidson, R., Armstrong, R., Cook, J., Hart, R., Morrison, P. J., Barwell, J. G., Donaldson, A., Kemp, Z., Murray, J., Miedzybrodzka, Z., Pottinger, C., Berg, J., Gallon, R., Bishop, D. T., Abu-Freha, N., Boussioutas, A., Eccles, D. M., Greenhalgh, L., Lacunza, A. G., Half, E. E., Hanson, H., Hart, R., Hayes, C. M., Job, D., Khan, Z., Kulkarni, A., Levi, Z., Longstaff, L., Fan, H. M., Mathers, J. C., Murday, V., Porteous, M. E., Pylvänäinen, K., Reed, L., Repana, D., Seppala, T. T., Shapira, S., Spigelman, A., Thygesen, H., Toh, J., & Wu, K. (2026). Aspirin for cancer prevention in individuals with Lynch syndrome: first results from the CaPP3 multicentre, randomised, double-blind, non-inferiority trial. The Lancet Gastroenterology & Hepatology. https://doi.org/10.1016/s2468-1253(26)00114-7
Source records
- crossref · retrieved 2026-09-26T06:12:34.898Z